We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Tamiz neonatal ampliado para fibrosis quística: un diagnóstico al alcance de la medicina preventiva.
- Authors
Jorge Matos-Alviso, Luis; Lizeth Reyes-Hernández, Katy; Reyes-Gómez, Ulises; Elena Vargas-Mosso, María; Berenica Aguilar-Román, Ana; Pineda-Gordillo, Adolfo; Quero-Hernández, Armando; López-Cruz, Gerardo; Ulises Reyes-Hernández, Manuel; Pablo Yalaupari-Mejía, Juan; González-Arenas, Efrén; Hernández-Lira, Idalia; Matías Soria-Saavedra, Francisco; Baeza Casillas, Javier Abel
- Abstract
The expanded Neonatal Sieve, which includes measuring immunoreactive trypsinogen levels for cystic fibrosis screening, is part of a more important public health effort and strategy (after vaccines) achieved in preventive medicine. It offers the opportunity to timely identify the probable carriers of the disease, allowing the diagnosis to be made in a pre-symptomatic stage to initiate treatment and timely follow-up avoiding major complications with short and long-term clinical benefit. The neonatal CF sieve is performed by measuring the amount of immunoreactive trypsinogen in neonatal blood samples obtained by heel puncture. However, despite being mandatory by the health law, it is not yet practiced in all newborns in our country. The neonatal sieve is not a diagnostic test. Patients with out-of-range results or with the presence of signs or symptoms suggestive of CF should undergo an investigation process and a sweat test for screening for more accurate detection.
- Publication
Boletin Clinico Hospital Infantil del Estado de Sonora, 2022, Vol 39, Issue 2, p52
- ISSN
1405-1303
- Publication type
Article